These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proceedings: Lipidosis-like ultrastructural alterations in rat tissues induced by an antidepressant drug (iprindole). Lüllmann HL; Lüllmann-Rauch R Br J Pharmacol; 1974 Mar; 50(3):473P. PubMed ID: 4853826 [No Abstract] [Full Text] [Related]
4. Origin of the pulmonary alveolar macrophage studied in the iprindole-treated rat. Vijeyaratnam GS; Corrin B J Pathol; 1972 Oct; 108(2):115-8. PubMed ID: 4647503 [No Abstract] [Full Text] [Related]
14. New indolyl MAO inhibitors. Part 2. Sathi G; Gujrati VR; Nath C; Bhargava KP; Shanker K Pharmazie; 1982 Dec; 37(12):868-9. PubMed ID: 7163376 [No Abstract] [Full Text] [Related]
15. Preclinical pharmacologic studies on 1-nitro-9-(dimethylaminopropylamino)-acridine and its n-oxide. II. Chronic action. Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J Arch Immunol Ther Exp (Warsz); 1972; 20(3):419-44. PubMed ID: 5055688 [No Abstract] [Full Text] [Related]
16. A new design for the screening of CNS-active drugs in mice. A multi-dimensional observation procedure and the study of pharmacological interactions. Morpurgo C Arzneimittelforschung; 1971 Nov; 21(11):1727-34. PubMed ID: 5172082 [No Abstract] [Full Text] [Related]